Biochemistry

Congratulations to our School of Medicine Basic Sciences faculty members who were promoted or received new appointments between January and March 2026! These individuals significantly enrich our pursuit of pathbreaking research and contribute to the growth and success of our school. Read More

Celebrate the 10-year anniversary of the School of Medicine Basic Sciences by revisiting the top 10 scientific discoveries and achievements in our short history. Read More

The biochemistry lab of Doug Mitchell discovered the enzyme responsible for a rare chemical modification that doesn't exist in human cells, which can potentially become a new target for developing antibiotics that selectively kill bacteria without harming our own cells. Read More

In honor of the 2026 Women’s History Month, the Vanderbilt University School of Medicine Basic Sciences is highlighting female faculty from our school. We asked them to reflect on their journeys and the changes they have experienced in how biomedical research and academia treat their women. Read More

Katrin Karbstein, the co-leader of the Cancer Cell Biology Research Program in the Vanderbilt-Ingram Cancer Center, will now expand her focus to support her department’s mission across research, service, and education, with a special focus on faculty affairs. Read More

Congratulations to our School of Medicine Basic Sciences faculty members who were promoted or received new appointments between October and December 2025! These individuals significantly enrich our pursuit of pathbreaking research and contribute to the growth and success of our school. Read More

As 2025 draws to a close, we reflect on the achievements and contributions to science made by the School of Medicine Basic Sciences community over the past year. SOMBS facilitates outstanding fundamental science research across four departments, two institutes, 10 centers, and 18 core facilities. The work of our faculty,… Read More

Hannah Collins was named the 2025 Destination Biochemistry Stanley Cohen Postdoctoral Scholar in recognition of her exceptional training, innovative research on microglial signaling, and strong potential as a future scientific leader. Joining Bruce Carter’s lab, she brings significant expertise and new perspectives to studies of the Jedi receptor in microglial function. Read More

The U.S. Food and Drug Administration has approved the use of the new antibiotic gepotidacin for use against uncomplicated gonorrhea. The biochemistry lab of Neil Osheroff provided all mechanism of action data in the FDA application. Read More

Meet Katherine Clowes Moster, a trainee in the lab of Chuck Sanders in the Department of Biochemistry. Read More